SE8405493D0
(sv)
*
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
US5314642A
(en)
*
|
1984-11-27 |
1994-05-24 |
Igen, Inc. |
Interaction system comprising a surfactant-stabilized aqueous phase containing an antibody fragment
|
DE3775783D1
(de)
*
|
1986-01-14 |
1992-02-20 |
Nederlanden Staat |
Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
|
US4806350A
(en)
*
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
CA1331355C
(en)
*
|
1986-04-21 |
1994-08-09 |
Bioenterprises Pty. Ltd |
Immunopotentation
|
FR2598434B1
(fr)
*
|
1986-05-12 |
1988-09-16 |
Pf Medicament |
Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
|
US4888169A
(en)
*
|
1986-10-14 |
1989-12-19 |
Norden Laboratories, Inc. |
Bordetella Bronchiseptica vaccine
|
EP0270295A3
(en)
*
|
1986-12-03 |
1989-08-02 |
Connaught Laboratories Limited |
Conjugate vaccine
|
US5976839A
(en)
*
|
1987-03-13 |
1999-11-02 |
Bioenterprises Pty Limited |
Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
|
FR2614306B1
(fr)
*
|
1987-04-22 |
1989-07-28 |
Pf Medicament |
Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
|
US5043158A
(en)
*
|
1987-08-21 |
1991-08-27 |
Chembiomed, Ltd. |
Immunogenic compositions containing ordered carriers
|
DE3727987A1
(de)
*
|
1987-08-21 |
1989-03-02 |
Sleytr Uwe B |
Pharmazeutische struktur
|
US5178860A
(en)
*
|
1989-09-01 |
1993-01-12 |
Coopers Animal Health Limited |
Adjuvant complexes and vaccine made therefrom
|
JPH049015U
(fi)
*
|
1990-05-09 |
1992-01-27 |
|
|
NL9002314A
(nl)
*
|
1990-10-23 |
1992-05-18 |
Nederlanden Staat |
Immunogene complexen, in het bijzonder iscoms.
|
DE69229476T2
(de)
*
|
1991-08-15 |
2000-03-16 |
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts |
Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
|
US6676942B1
(en)
|
1991-08-15 |
2004-01-13 |
Smithkline Beecham Biologicals (S.A.) |
Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
|
GB9207731D0
(en)
*
|
1992-04-07 |
1992-05-27 |
Proteus Molecular Design |
Improvements in or relating to vaccines
|
EP0604727A1
(en)
*
|
1992-12-31 |
1994-07-06 |
American Cyanamid Company |
Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen
|
JP4129544B2
(ja)
*
|
1993-03-29 |
2008-08-06 |
ファイザー・インク |
サポニンアジュバント使用の多成分系クロストリジウム・ワクチン
|
JPH0756123A
(ja)
*
|
1993-08-20 |
1995-03-03 |
Nakanishi Opt:Kk |
眼鏡フレーム
|
GB9320597D0
(en)
*
|
1993-10-06 |
1993-11-24 |
Proteus Molecular Design |
Improvements in and realting to vaccines
|
AUPM500494A0
(en)
*
|
1994-04-12 |
1994-05-05 |
Minister For Agriculture & Rural Affairs For The State Of New South Wales, The |
Composition for use in increasing mucosal immunity
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
WO1996023061A2
(en)
*
|
1995-01-27 |
1996-08-01 |
Genencor International, Inc. |
Surfactant-based enzyme extraction process
|
US20030190323A1
(en)
*
|
1995-07-05 |
2003-10-09 |
Yeda Research And Development Co. Ltd. |
Preparations and methods for the treatment of T cell mediated diseases
|
US6488933B2
(en)
|
1995-07-05 |
2002-12-03 |
Yeda Research And Development Co. Ltd. |
Preparations for the treatment of T cell mediated diseases
|
IL114458A0
(en)
*
|
1995-07-05 |
1995-11-27 |
Yeda Res & Dev |
Therapeutic preparations for treatment of T cell mediated diseases
|
AUPO517897A0
(en)
*
|
1997-02-19 |
1997-04-11 |
Csl Limited |
Chelating immunostimulating complexes
|
AUPO732997A0
(en)
|
1997-06-12 |
1997-07-03 |
Csl Limited |
Ganglioside immunostimulating complexes and uses thereof
|
US6455323B1
(en)
|
1997-07-03 |
2002-09-24 |
Pharmacia & Upjohn Company |
Anti-bacterial methods and materials
|
WO1999006836A1
(fr)
|
1997-08-04 |
1999-02-11 |
Tonen Corporation |
Methodes permettant de detecter ou d'analyser un virus
|
ID29082A
(id)
*
|
1998-09-22 |
2001-07-26 |
Molecular Express Inc |
Komposisi liposom imunogenik
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
AU783344B2
(en)
*
|
1999-02-17 |
2005-10-20 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
US6790950B2
(en)
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
ES2439645T3
(es)
|
1999-04-09 |
2014-01-24 |
Zoetis P&U Llc |
Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
|
ES2244617T3
(es)
|
2000-03-17 |
2005-12-16 |
Pharmacia & Upjohn Co Llc |
Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
|
AU2001251370A1
(en)
|
2000-04-06 |
2001-10-23 |
Pharmacia And Upjohn Company |
Antimicrobial methods and materials
|
US7323174B1
(en)
|
2000-06-12 |
2008-01-29 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Modulation of immune response and methods based thereon
|
AUPR011700A0
(en)
|
2000-09-14 |
2000-10-05 |
Austin Research Institute, The |
Composition comprising immunogenic virus sized particles (VSP)
|
AU2002211669A1
(en)
|
2000-10-12 |
2002-04-22 |
Robert Corcoran |
Purification of substance by reaction affinity chromatography
|
US7713942B2
(en)
*
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
GB0112126D0
(en)
|
2001-05-18 |
2001-07-11 |
Allergene Inc |
Composition
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
DE60327925D1
(de)
*
|
2002-03-01 |
2009-07-23 |
Gary Levy |
Verwendung von löslichem fgl2 als immunosuppressivum
|
SE0202110D0
(sv)
*
|
2002-07-05 |
2002-07-05 |
Isconova Ab |
Iscom preparation and use thereof
|
BR0313237A
(pt)
|
2002-08-12 |
2005-07-12 |
Akzo Nobel Nv |
Sequência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hospedeira, proteìna de streptococcus uberis, usos da mesma e de uma sequência de ácido nucleico, de um fragmento de dna, de uma molécula de dna recombinante, de um veìculo recombinante vivo, de uma célula hospedeira ou de uma proteìna ou de um fragmento imunogênico da mesma, vacina, método para a preparação da mesma, e, kit diagnóstico
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
US20050026859A1
(en)
*
|
2002-11-12 |
2005-02-03 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
US7491395B2
(en)
|
2002-11-20 |
2009-02-17 |
Bestewil Holding B.V. |
Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
|
ATE494909T1
(de)
|
2002-11-20 |
2011-01-15 |
Bestewil Holding Bv |
Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung
|
AR056245A1
(es)
|
2003-06-19 |
2007-10-03 |
Bestewil Holding Bv |
Membranas virales reconstituidas funcionales que contienen un coadyuvante
|
US9023366B2
(en)
|
2003-07-01 |
2015-05-05 |
The Royal Veterinary College |
Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
|
GB0315323D0
(en)
|
2003-07-01 |
2003-08-06 |
Royal Veterinary College |
Vaccine composition
|
CA2565500A1
(en)
|
2004-05-28 |
2005-12-15 |
Glaxosmithkline Biologicals S.A. |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
EP1896067B1
(en)
|
2005-06-16 |
2011-07-20 |
Universiteit Gent |
Vaccines for immunization against helicobacter
|
ES2357679T3
(es)
|
2005-07-28 |
2011-04-28 |
Pfizer Products Inc. |
VACUNA CONTRA CALICIVIRUS FELINO (FCV) QUE COMPRENDE UNA PROTEINA DE CAPSIDA DE UN FCV O UNA PROTEINA DE LA CAPSIDA DE UN FCV AISLADA QUE COMPRENDE UNA SECUENCIA PROTEICA SEC ID Nº: 13 O SECUENCIAS PROTEICAS CON, AL MENOS, 95% DE IDENTIDAD CON ELLA.
|
RU2396976C2
(ru)
|
2005-10-07 |
2010-08-20 |
Пфайзер Продактс Инк. |
Вакцины и способы лечения собачьего гриппа
|
TW200806315A
(en)
*
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
US20100028379A1
(en)
|
2006-12-27 |
2010-02-04 |
Pfizer, Inc |
Methods of vaccine administration
|
ES2962777T3
(es)
|
2007-11-15 |
2024-03-21 |
Amgen Inc |
Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral
|
JP2011507523A
(ja)
*
|
2007-12-21 |
2011-03-10 |
ワイス・エルエルシー |
遺伝子改変した弱毒化水疱性口内炎ウイルス、組成物およびその使用方法
|
EP2303318A2
(en)
|
2008-06-20 |
2011-04-06 |
Wyeth LLC |
Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
|
NZ597191A
(en)
|
2009-06-22 |
2013-11-29 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
BRPI1015567A2
(pt)
|
2009-06-22 |
2021-08-31 |
Wyeth Llc |
Composições imunogênicas de antígenos de staphylococcus aureus
|
WO2011048041A1
(en)
|
2009-10-19 |
2011-04-28 |
Intervet International B.V. |
Streptococcal combi-vaccine
|
BR112012009212A2
(pt)
|
2009-10-22 |
2017-06-20 |
Univ Leipzig |
'aplasia de medula óssea com doença hemorrágica em bezerros causada por um novo agente patogênico"
|
DK179920B1
(en)
|
2010-04-21 |
2019-10-07 |
Pharmaq As |
Nucleic acid sequences of a fish virus and its use
|
KR20180082633A
(ko)
|
2010-05-14 |
2018-07-18 |
박스알타 인코퍼레이티드 |
Ospa 키메라 및 백신에서 그의 용도
|
EP2575870B1
(en)
|
2010-06-04 |
2016-12-07 |
Wyeth LLC |
Vaccine formulations
|
WO2012010291A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
WO2012010290A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
CA2805741C
(en)
|
2010-07-23 |
2019-08-13 |
Karin Bengtsson Loevgren |
Composition including an iscom matrix and ectodomains
|
EP3246044B2
(en)
|
2010-08-23 |
2024-04-10 |
Wyeth LLC |
Stable formulations of neisseria meningitidis rlp2086 antigens
|
US8628947B2
(en)
|
2010-08-30 |
2014-01-14 |
Intervet Inc. |
Potomac horse fever isolates
|
ES2864635T3
(es)
|
2010-09-10 |
2021-10-14 |
Wyeth Llc |
Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
|
WO2012059592A1
(en)
|
2010-11-05 |
2012-05-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Compounds for delivering a therapeutic or imaging agent to the brain
|
NO2640832T3
(fi)
|
2010-11-15 |
2018-05-19 |
|
|
EP2462950A1
(en)
|
2010-12-08 |
2012-06-13 |
Neovacs |
Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof
|
MX2013006501A
(es)
|
2010-12-08 |
2014-02-28 |
Neovacs |
Vacuna fuertemente inactivada y todavia sumamente inmunogenica, y proceso para su fabricacion.
|
AU2011346535B2
(en)
|
2010-12-22 |
2015-09-24 |
Wyeth Llc |
Stable immunogenic compositions of Staphylococcus aureus antigens
|
US9139618B2
(en)
|
2010-12-29 |
2015-09-22 |
Intervet Inc. |
Salmonid alphavirus protein E2
|
US20130287786A1
(en)
|
2010-12-29 |
2013-10-31 |
Theodorus Petrus Maria Schetters |
Canine babesiosis vaccine antigen
|
EP2691111B1
(en)
|
2011-03-31 |
2017-09-20 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
|
PT2694094T
(pt)
|
2011-04-07 |
2017-11-06 |
Neovacs |
Método para tratar afeções relacionadas com ifn alfa
|
EP2508197A1
(en)
|
2011-04-07 |
2012-10-10 |
Neovacs |
Method for treating IFNalpha related conditions
|
CN110680913A
(zh)
|
2011-05-13 |
2020-01-14 |
硕腾有限公司 |
亨德拉和尼帕病毒g糖蛋白免疫原性组合物
|
ITMI20111182A1
(it)
|
2011-06-28 |
2012-12-29 |
Canio Buonavoglia |
Vaccino per coronavirus canino
|
MX2014000753A
(es)
*
|
2011-07-20 |
2014-05-07 |
Abbott Biologicals Bv |
Procedimiento para producir antigeno viral y vacunas.
|
AU2012306282A1
(en)
|
2011-09-08 |
2014-03-20 |
Umc Utrecht Holding B.V. |
Vaccine based on Staphylococcal superantigen-like 3 protein (SSL3)
|
EP2750683B2
(en)
|
2011-10-03 |
2021-01-06 |
Croda International PLC |
Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
|
GB201200259D0
(en)
|
2012-01-09 |
2012-02-22 |
Ohlin Per M |
Novel therapies
|
MY167723A
(en)
|
2012-03-09 |
2018-09-21 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
CN104640563A
(zh)
|
2012-07-27 |
2015-05-20 |
巴克斯特国际公司 |
包含嵌合的ospa分子的组合物及其使用方法
|
EP4169929A1
(en)
|
2012-12-20 |
2023-04-26 |
Pfizer Inc. |
Immunogenic compositions comprising pn-serotype 12f
|
ES2685894T3
(es)
|
2013-03-08 |
2018-10-15 |
Pfizer Inc. |
Polipéptidos de fusión inmunogénicos
|
US10294277B2
(en)
|
2013-03-26 |
2019-05-21 |
The Pirbright Institute |
Stabilised FMDV capsids
|
WO2014163558A1
(en)
|
2013-04-01 |
2014-10-09 |
Moreinx Ab |
Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
|
WO2015033251A2
(en)
|
2013-09-08 |
2015-03-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
CN105828836A
(zh)
|
2013-12-16 |
2016-08-03 |
硕腾服务有限责任公司 |
亨德拉病毒和尼帕病毒g糖蛋白免疫原性组合物
|
WO2016130569A1
(en)
|
2015-02-09 |
2016-08-18 |
Mj Biologics, Inc. |
A composition comprising pedv antigens and methods for making and using the composition
|
CN106535930A
(zh)
|
2014-03-11 |
2017-03-22 |
明尼苏达大学董事会 |
猪流行性腹泻病毒疫苗及其使用方法
|
AU2015310932B2
(en)
|
2014-09-03 |
2018-11-22 |
Intervet International B.V. |
Attenuated bovine coronavirus and related vaccines
|
PL3200820T3
(pl)
|
2014-10-03 |
2023-09-18 |
Intervet International B.V. |
Szczepionka o szerokim spektrum działania przeciwko reowirusowi ptasiemu
|
EP3613764A1
(en)
|
2014-10-15 |
2020-02-26 |
Xenothera |
Composition with reduced immunogenicity
|
KR20190049940A
(ko)
|
2015-02-19 |
2019-05-09 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
CN107533060B
(zh)
|
2015-03-10 |
2019-11-05 |
生物辐射实验室股份有限公司 |
组合密螺旋体和非密螺旋体梅毒测试
|
PE20180172A1
(es)
|
2015-05-04 |
2018-01-22 |
Pfizer |
Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos
|
CN114617959A
(zh)
|
2015-09-03 |
2022-06-14 |
诺瓦瓦克斯股份有限公司 |
具有改进的稳定性和免疫原性的疫苗组合物
|
GB2551984B
(en)
|
2016-06-30 |
2019-01-16 |
Pharmaq As |
Fish virus
|
WO2018035199A1
(en)
|
2016-08-17 |
2018-02-22 |
Pharmaq As |
Sea lice vaccine
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
AU2018331357A1
(en)
|
2017-09-18 |
2020-04-02 |
Bayer Healthcare Llc |
Methods of inactivation of viruses using N-methylglucamides and its Derivatives
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
EP4136095A1
(en)
|
2020-04-17 |
2023-02-22 |
Regents of the University of Minnesota |
Sars-cov-2 spike receptor binding domain and compositions and methods thereof
|
EP3922255A1
(en)
|
2020-06-10 |
2021-12-15 |
Prokarium Limited |
Cancer therapy
|
EP4203995A1
(en)
|
2020-08-26 |
2023-07-05 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
CA3203043A1
(en)
|
2020-12-23 |
2022-06-30 |
Odile DUVAUX |
Composition of pig polyclonal antibody for its use to treat and/or prevent antibody-dependent macrophage pro-inflammatory cytokine release in a passive anti-infectious immunotherap
|
EP4124342A1
(en)
|
2021-07-28 |
2023-02-01 |
Prokarium Limited |
Cancer therapy with live attenuated bacteria
|
GB2622559A
(en)
|
2022-05-10 |
2024-03-27 |
Johan Frostegaard |
Compositions, methods and uses
|
WO2023225458A1
(en)
|
2022-05-16 |
2023-11-23 |
Zoetis Services Llc |
Vaccines against moritella viscosa
|
GB202209588D0
(en)
|
2022-06-29 |
2022-08-10 |
Plant Bioscience Ltd |
Methods and compositions
|
WO2024069420A2
(en)
|
2022-09-29 |
2024-04-04 |
Pfizer Inc. |
Immunogenic compositions comprising an rsv f protein trimer
|
GB202215134D0
(en)
|
2022-10-13 |
2022-11-30 |
Prokarium Ltd |
Composition
|
GB202215576D0
(en)
|
2022-10-21 |
2022-12-07 |
Prokarium Ltd |
Circuit
|
WO2024153674A1
(en)
|
2023-01-18 |
2024-07-25 |
Novavax AB |
Methods of quantifying saponins present in particles comprising saponin and lipid
|